[1]王海星,尹德春,曲秀芬.病态窦房结综合征的心房纤维化血清学指标研究进展[J].心血管病学进展,2020,(3):310-313.[doi:10.16806/j.cnki. issn.1004-3934.2020.03.023]
　WANG Haixing,YIN Dechun,QU Xiufen.Serological Indicators of Atrial Fibrosis for Sick Sinus Syndrome[J].Advances in Cardiovascular Diseases,2020,(3):310-313.[doi:10.16806/j.cnki. issn.1004-3934.2020.03.023]
点击复制

病态窦房结综合征的心房纤维化血清学指标研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年3期
页码:
310-313
栏目:
综述
出版日期:
2020-03-25

文章信息/Info

Title:
Serological Indicators of Atrial Fibrosis for Sick Sinus Syndrome
作者:
王海星 ; 尹德春 ; 曲秀芬
(哈尔滨医科大学附属第一临床医学院心内科,黑龙江 哈尔滨 150000)
Author(s):
WANG Haixing;  YIN Dechun;  QU Xiufen
(Department of Cardiology,The First Affiliated Hospital of Harbin Medical University,Harbin 150000,Heilongjiang,China)
关键词:
心房纤维化; 病态窦房结综合征; 血清学指标; 血管紧张素Ⅱ; 利钠肽
Keywords:
Atrial fibrosis ; Sick sinus syndrome ; Serological indicators ; Angiotensin Ⅱ; Natriuretic peptide
DOI:
10.16806/j.cnki. issn.1004-3934.2020.03.023
摘要:
病态窦房结综合征是临床上比较常见的一种心律失常，主要导致患者产生乏力和晕厥等不适，严重时可引起心脏性猝死。血清学检验指标具有取样方便和价格相对低廉等优势，易于在临床中广泛开展，近几年发现心房纤维化在病态窦房结综合征的发生和发展中起重要作用，但心房纤维化的血清学指标未引起临床的足够重视。现主要论述心房纤维化与病态窦房结综合征的关系以及利用血清学检验指标筛查病态窦房结综合征患者心房纤维化的研究进展，指导临床对心房纤维化进行积极干预，改善患者预后。
Abstract:
Sick sinus syndrome(SSS) is a kind of common arrhythmia clinically .It can causes fatigue,syncope and other discomfort in patient,and severe cases can even result in sudden cardiac death. Serological indicators have many advantages in sampling collection,economic costs and so on ,which are easy to be widely used in clinical practice. Recent researches have found that atrial fibrosis plays a key role in the occurrence and development of SSS,but the serological testing indicators of atrial fibrosis for SSS still have not got enough attention. This paper mainly discusses the relationship between atrial fibrosis and SSS,and research progress in serological testing indicators of atrial fibrosis for SSS,thereby guiding the clinical active intervention in atrial fibrosis and improve the prognosis of patients

参考文献/References:

[1]Jackson LR 2 nd,Rathakrishnan B,Campbell K,et al. Sinus node dysfunction and atrial fibrillation:a reversible phenomenon?[J]. Pacing Clin Electrophysiol,2017,40(4):442-450.

[2]袁朝汉,张焕基,伍贵富. 心房颤动发生及维持机制研究新进展[J]. 心血管病学进展,2017,38(5):520-522.

[3]Ku? J,Stallmeyer B,Goldstein M,et al. Familial sinus node disease caused by a gain of GIRK(G-Protein Activated InwardlyRectifying K+ Channel) channel function[J]. Circ Genom Precis Med,2019,12(1):e002238.

[4]Hayashi H,Sumiyoshi M,Nakazato Y,et al. Brugada syndrome and sinus node dysfunction[J]. J Arrhythm,2018,34(3) :216-221.

[5]de Ponti R,Marazzato J,Bagliani G,et al. Sick sinus syndrome[J]. Card Electrophysiol Clin,2018,10(2):183-195.

[6]Burstein B,Nattel S. Atrial fibrosis:mechanisms and clinical relevance in atrial fibrillation[J]. J Am Coll Cardiol,2008,51(8):802-809.

[7]Korantzopoulos P,Letsas KP,Tse G,et al. Inflammation and atrial fibrillation:a comprehensive review[J]. J Arrhythm,2018,34 (4):394-401.

[8]Jackson LR 2nd,Rathakrishnan B,Campbell K,et al. Sinus node dysfunction and atrial fibrillation:a reversible phenomenon?[J]. Pacing Clin Electrophysiol,2017,40(4):442-450.

[9]Nattel S. Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation[J]. JACC Clin Electrophysiol,2017,3(5):425-435.

[10]Thanigaimani S,Lau DH,Agbaedeng T,et al. Molecular mechanisms of atrial fibrosis:implications for the clinic[J]. Expert Rev Cardiovasc Ther,2017,15(4):247-256.

[11]Huang GY,Peng Z,Zhan Y,et al. Relationship between the change in pacing threshold and the myocardial injury[J]. Eur Rev Med Pharmacol Sci,2017,21(24):5774-5780.

[12]Bellmann B,Roser M,Muntean B,et al. Atrial standstill in sinus node disease due to extensive atrial fibrosis:impact on dual chamber pacemaker implantation[J]. Europace,2016,18(2):238-245.

[13]Benito EM,de Luna AB,Baranchuk A,et al. Extensive atrial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance associated with advanced interatrial block electrocardiogram pattern[J]. Europace,2017,19(3):377-377.

[14]马新欣,张跃力. 超声心动图评价左心房重构的应用[J]. 中国医学影像技术,2015,31(12):1915-1918.

[15]Wang GD,Shen LH,Wang L,et al. Relationship between integrated backscatter and atrial fibrosis in patients with and without atrial fibrillation who are undergoing coronary bypass surgery[J]. Clin Cardiol,2009,32(9):E56-E61.

[16]Cameli M,Lisi M,Righini FM,et al. Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse[J]. Am J Cardiol,2013,111(4):595-601.

[17]Fu X,Kassim SY,Parks WC,et al. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7(matrilysin):an oxidative mechanism for restraining proteolytic activity during inflammation[J]. J Biol Chem,2003,278(31):28403-28409.

[18]Rudolph V,Andrié RP,Rudolph TK,et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation[J]. Nat Med,2010,16(4):470-474.

[19]Weymann A,Popov AF,Sabashnikov A,et al. Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery:a systematic review and meta-analysis[J]. Kardiol Pol,2018,76(2):440-451.

[20]Scott L,Li N,Dobrev D. Role of inflammatory signaling in atrial fibrillation[J]. Int J Cardiol,2019,287:195-200.

[21]Karam BS,Chavez-Moreno A,Koh W,et al. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes[J]. Cardiovasc Diabetol,2017,16(1):120.

[22]Liu L,Wu L,Zheng L,et al. Associations between multiple circulating biomarkers and the presence of atrial fibrillation in hypertrophic cardiomyopathy with or without left ventricular outflow tract obstruction[J]. Int Heart J,2019,60(2):327-335.

[23]曹哲哲,马瑞彦. 心房颤动的心房纤维化分子机制研究进展[J]. 心血管病学进展,2019,40(3):359-362.

[24]Kim N,Jung Y,Nam M,et al. AngiotensinⅡaffects inflammation mechanisms via AMPK-related signalling pathways in HL-1 atrial myocytes[J]. Sci Rep,2017,7(1):10328.

[25]Tadevosyan A,Xiao J,Surinkaew S,et al. Intracellular angiotensin-Ⅱinteracts with nuclear angiotensin receptors in cardiac fibroblasts and regulates RNA synthesis,cell proliferation,and collagen secretion[J]. J Am Heart Assoc,2017,6(4):e004965.

[26]王燕,许纲,程立君,等. 心房纤维化研究进展[J]. 心血管病学进展,2019,40(3):389-392.

[27]Jansen HJ,Mackasey M,Moghtadaei M,et al. Distinct patterns of atrial electrical and structural remodeling in angiotensinⅡ mediated atrial fibrillation[J]. J Mol Cell Cardiol,2018,124:12-25.

[28]Walters TE,Kalman JM,Patel SK,et al. Angiotensin converting enzyme 2 activity and human atrial fibrillation:increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling[J]. Europace,2017,19(8):1280-1287.

[29]Kerkel R,Ulvila J,Magga J. Natriuretic peptides in the regulation of cardiovascular physiology and metabolic events[J]. J Am Heart Assoc,2015,4(10):e002423.

[30]Tsai YT,Lin FY,Lin CS,et al. B-type natriuretic peptide enhances fibrotic effects via matrix metalloproteinase-2 expression in the mouse atrium in vivo and in human atrial myofibroblasts in vitro[J]. Transl Res,2019,208:30-46.

[31]Nattel S. Natriuretic protein receptors and atrial selective fibrosis:potential role in atrial fibrillation[J]. Cardiovasc Res,2019,115(2):258-260.

相似文献/References:

[1]吴亦融 徐健.心房颤动患者心房传导速度研究进展[J].心血管病学进展,2019,(9):1212.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.007]
　WU Yirong,XU Jian.Atrial Conduction Velocity in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(3):1212.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.007]
[2]张佳圩 黄从新.预防心房纤维化对心房颤动患者射频消融术后复发的影响[J].心血管病学进展,2020,(1):89.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.024]
　ZhANG Jiawei,HUANG Congxin.Prevention of Atrial Fibrosis Affects Atrial Fibrillation Recurrence after Radiofrequency Ablation[J].Advances in Cardiovascular Diseases,2020,(3):89.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.024]
[3]王国昊 张荣峰.缓慢性心律失常的遗传学研究进展[J].心血管病学进展,2022,(11):978.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.004]
　WANG Guohao,ZHANG Rongfeng.Genetics of Bradyarrhythmias[J].Advances in Cardiovascular Diseases,2022,(3):978.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.004]
[4]贾春森 李磊 李劲平 谭宏伟 周伟 聂永梅 于风旭.AngⅡ通过抑制人心房成纤维细胞BKCa通道诱导心房纤维化[J].心血管病学进展,2023,(11):1047.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.020]
　JIA Chunsen,LI Lei,LI Jinping,et al.Ang Induces Atrial Fibrosis by Inhibiting BKCa Channel in Human Atrial Fibroblast[J].Advances in Cardiovascular Diseases,2023,(3):1047.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.020]

备注/Memo

备注/Memo:
收稿日期：2019-06-30 基金项目：中国博士后面上资助项目(2018M631959） 通讯作者：曲秀芬，E-mail：2093445184@qq.com
更新日期/Last Update: 2020-05-20